Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.

The Global Info Research report includes an overview of the development of the PET Radioisotope (Radiopharmaceuticals in PET Imaging) industry chain, the market status of Medical Imaging (11C, 13N), Scientific Research (11C, 13N), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of PET Radioisotope (Radiopharmaceuticals in PET Imaging).

Regionally, the report analyzes the PET Radioisotope (Radiopharmaceuticals in PET Imaging) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the PET Radioisotope (Radiopharmaceuticals in PET Imaging) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., 11C, 13N).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market.

Regional Analysis: The report involves examining the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to PET Radioisotope (Radiopharmaceuticals in PET Imaging):
Company Analysis: Report covers individual PET Radioisotope (Radiopharmaceuticals in PET Imaging) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards PET Radioisotope (Radiopharmaceuticals in PET Imaging) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medical Imaging, Scientific Research).

Technology Analysis: Report covers specific technologies relevant to PET Radioisotope (Radiopharmaceuticals in PET Imaging). It assesses the current state, advancements, and potential future developments in PET Radioisotope (Radiopharmaceuticals in PET Imaging) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
PET Radioisotope (Radiopharmaceuticals in PET Imaging) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    11C
    13N
    150
    18F
    Others

Market segment by Application
    Medical Imaging
    Scientific Research

Major players covered
    IBA Molecular
    GE Healthcare
    Siemens Healthineers
    Eli Lilly and Company
    Mallinckrodt Pharmaceuticals
    Blue Earth Diagnostics
    ANSTO
    ROSATOM

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PET Radioisotope (Radiopharmaceuticals in PET Imaging) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), with price, sales, revenue and global market share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) from 2019 to 2024.
Chapter 3, the PET Radioisotope (Radiopharmaceuticals in PET Imaging) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PET Radioisotope (Radiopharmaceuticals in PET Imaging) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and PET Radioisotope (Radiopharmaceuticals in PET Imaging) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PET Radioisotope (Radiopharmaceuticals in PET Imaging).
Chapter 14 and 15, to describe PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 11C
        1.3.3 13N
        1.3.4 150
        1.3.5 18F
        1.3.6 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Medical Imaging
        1.4.3 Scientific Research
    1.5 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size & Forecast
        1.5.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (2019-2030)
        1.5.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 IBA Molecular
        2.1.1 IBA Molecular Details
        2.1.2 IBA Molecular Major Business
        2.1.3 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
        2.1.4 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 IBA Molecular Recent Developments/Updates
    2.2 GE Healthcare
        2.2.1 GE Healthcare Details
        2.2.2 GE Healthcare Major Business
        2.2.3 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
        2.2.4 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 GE Healthcare Recent Developments/Updates
    2.3 Siemens Healthineers
        2.3.1 Siemens Healthineers Details
        2.3.2 Siemens Healthineers Major Business
        2.3.3 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
        2.3.4 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Siemens Healthineers Recent Developments/Updates
    2.4 Eli Lilly and Company
        2.4.1 Eli Lilly and Company Details
        2.4.2 Eli Lilly and Company Major Business
        2.4.3 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
        2.4.4 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Eli Lilly and Company Recent Developments/Updates
    2.5 Mallinckrodt Pharmaceuticals
        2.5.1 Mallinckrodt Pharmaceuticals Details
        2.5.2 Mallinckrodt Pharmaceuticals Major Business
        2.5.3 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
        2.5.4 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
    2.6 Blue Earth Diagnostics
        2.6.1 Blue Earth Diagnostics Details
        2.6.2 Blue Earth Diagnostics Major Business
        2.6.3 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
        2.6.4 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Blue Earth Diagnostics Recent Developments/Updates
    2.7 ANSTO
        2.7.1 ANSTO Details
        2.7.2 ANSTO Major Business
        2.7.3 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
        2.7.4 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 ANSTO Recent Developments/Updates
    2.8 ROSATOM
        2.8.1 ROSATOM Details
        2.8.2 ROSATOM Major Business
        2.8.3 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
        2.8.4 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 ROSATOM Recent Developments/Updates

3 Competitive Environment: PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Manufacturer
    3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Manufacturer (2019-2024)
    3.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturer Market Share in 2023
        3.4.2 Top 6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturer Market Share in 2023
    3.5 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Overall Company Footprint Analysis
        3.5.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Region Footprint
        3.5.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Type Footprint
        3.5.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Region
        4.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2019-2030)
        4.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2019-2030)
        4.1.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2019-2030)
    4.2 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
    4.3 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
    4.4 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
    4.5 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
    4.6 Middle East and Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
    5.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Type (2019-2030)
    5.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
    6.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Application (2019-2030)
    6.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2030)

7 North America
    7.1 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
    7.2 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
    7.3 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Country
        7.3.1 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2030)
        7.3.2 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
    8.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
    8.3 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Country
        8.3.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2030)
        8.3.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Region
        9.3.1 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
    10.2 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
    10.3 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Country
        10.3.1 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2030)
        10.3.2 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size by Country
        11.3.1 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers
    12.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Restraints
    12.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of PET Radioisotope (Radiopharmaceuticals in PET Imaging) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
    13.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Process
    13.4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Distributors
    14.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. IBA Molecular Basic Information, Manufacturing Base and Competitors
    Table 4. IBA Molecular Major Business
    Table 5. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
    Table 6. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. IBA Molecular Recent Developments/Updates
    Table 8. GE Healthcare Basic Information, Manufacturing Base and Competitors
    Table 9. GE Healthcare Major Business
    Table 10. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
    Table 11. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. GE Healthcare Recent Developments/Updates
    Table 13. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
    Table 14. Siemens Healthineers Major Business
    Table 15. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
    Table 16. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Siemens Healthineers Recent Developments/Updates
    Table 18. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
    Table 19. Eli Lilly and Company Major Business
    Table 20. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
    Table 21. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Eli Lilly and Company Recent Developments/Updates
    Table 23. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 24. Mallinckrodt Pharmaceuticals Major Business
    Table 25. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
    Table 26. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Mallinckrodt Pharmaceuticals Recent Developments/Updates
    Table 28. Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors
    Table 29. Blue Earth Diagnostics Major Business
    Table 30. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
    Table 31. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Blue Earth Diagnostics Recent Developments/Updates
    Table 33. ANSTO Basic Information, Manufacturing Base and Competitors
    Table 34. ANSTO Major Business
    Table 35. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
    Table 36. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. ANSTO Recent Developments/Updates
    Table 38. ROSATOM Basic Information, Manufacturing Base and Competitors
    Table 39. ROSATOM Major Business
    Table 40. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
    Table 41. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. ROSATOM Recent Developments/Updates
    Table 43. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Manufacturer (2019-2024) & (Tons)
    Table 44. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 45. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturer (2019-2024) & (US$/Ton)
    Table 46. Market Position of Manufacturers in PET Radioisotope (Radiopharmaceuticals in PET Imaging), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 47. Head Office and PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Site of Key Manufacturer
    Table 48. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Type Footprint
    Table 49. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Application Footprint
    Table 50. PET Radioisotope (Radiopharmaceuticals in PET Imaging) New Market Entrants and Barriers to Market Entry
    Table 51. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2019-2024) & (Tons)
    Table 53. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2025-2030) & (Tons)
    Table 54. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2019-2024) & (USD Million)
    Table 55. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2025-2030) & (USD Million)
    Table 56. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2019-2024) & (US$/Ton)
    Table 57. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2025-2030) & (US$/Ton)
    Table 58. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2024) & (Tons)
    Table 59. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2025-2030) & (Tons)
    Table 60. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Type (2019-2024) & (USD Million)
    Table 61. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Type (2025-2030) & (USD Million)
    Table 62. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2024) & (US$/Ton)
    Table 63. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2025-2030) & (US$/Ton)
    Table 64. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2024) & (Tons)
    Table 65. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2025-2030) & (Tons)
    Table 66. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2024) & (US$/Ton)
    Table 69. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2025-2030) & (US$/Ton)
    Table 70. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2024) & (Tons)
    Table 71. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2025-2030) & (Tons)
    Table 72. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2024) & (Tons)
    Table 73. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2025-2030) & (Tons)
    Table 74. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2024) & (Tons)
    Table 75. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2025-2030) & (Tons)
    Table 76. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2024) & (USD Million)
    Table 77. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2025-2030) & (USD Million)
    Table 78. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2024) & (Tons)
    Table 79. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2025-2030) & (Tons)
    Table 80. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2024) & (Tons)
    Table 81. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2025-2030) & (Tons)
    Table 82. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2024) & (Tons)
    Table 83. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2025-2030) & (Tons)
    Table 84. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2024) & (Tons)
    Table 87. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2025-2030) & (Tons)
    Table 88. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2024) & (Tons)
    Table 89. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2025-2030) & (Tons)
    Table 90. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2019-2024) & (Tons)
    Table 91. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2025-2030) & (Tons)
    Table 92. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2019-2024) & (USD Million)
    Table 93. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2025-2030) & (USD Million)
    Table 94. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2024) & (Tons)
    Table 95. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2025-2030) & (Tons)
    Table 96. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2024) & (Tons)
    Table 97. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2025-2030) & (Tons)
    Table 98. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2024) & (Tons)
    Table 99. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2025-2030) & (Tons)
    Table 100. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2024) & (USD Million)
    Table 101. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2025-2030) & (USD Million)
    Table 102. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2024) & (Tons)
    Table 103. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2025-2030) & (Tons)
    Table 104. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2024) & (Tons)
    Table 105. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2025-2030) & (Tons)
    Table 106. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2019-2024) & (Tons)
    Table 107. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2025-2030) & (Tons)
    Table 108. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2019-2024) & (USD Million)
    Table 109. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2025-2030) & (USD Million)
    Table 110. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Raw Material
    Table 111. Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging) Raw Materials
    Table 112. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Distributors
    Table 113. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Customers
List of Figures
    Figure 1. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Picture
    Figure 2. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Type in 2023
    Figure 4. 11C Examples
    Figure 5. 13N Examples
    Figure 6. 150 Examples
    Figure 7. 18F Examples
    Figure 8. Others Examples
    Figure 9. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 10. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Application in 2023
    Figure 11. Medical Imaging Examples
    Figure 12. Scientific Research Examples
    Figure 13. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (2019-2030) & (Tons)
    Figure 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price (2019-2030) & (US$/Ton)
    Figure 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2030) & (US$/Ton)
    Figure 32. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Application (2019-2030)
    Figure 33. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Application (2019-2030)
    Figure 34. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2030) & (US$/Ton)
    Figure 35. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Application (2019-2030)
    Figure 37. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Application (2019-2030)
    Figure 44. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Application (2019-2030)
    Figure 53. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Region (2019-2030)
    Figure 55. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Application (2019-2030)
    Figure 63. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Application (2019-2030)
    Figure 69. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers
    Figure 76. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Restraints
    Figure 77. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging) in 2023
    Figure 80. Manufacturing Process Analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
    Figure 81. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM